Sylvamo (SLVM) director receives 7,623 RSUs in deferred 2026-2027 board compensation
Rhea-AI Filing Summary
Sylvamo Corp director David D. Petratis received an equity award rather than buying shares on the market. He was granted 7,623 common-share–equivalent restricted stock units at a reference price of $38.70 per share, increasing his direct holdings to 35,106 shares. The grant covers service for the 2026-2027 performance year. The award consists of 3,876 time-based RSUs and 3,747 RSUs taken in lieu of a cash retainer, which will convert one-for-one into common stock on the earlier of May 13, 2027, or the next annual shareowners meeting. Settlement of the vested RSUs is deferred until the earlier of May 13, 2032, or the end of his board service.
Positive
- None.
Negative
- None.
Insights
Routine director equity grant; compensation-related, not a market purchase.
Director David D. Petratis received 7,623 restricted stock units, tied to his 2026-2027 board service, at a reference price of $38.70 per share. This is standard equity-based compensation rather than an open-market trade.
The award mixes 3,876 time-based RSUs and 3,747 RSUs in lieu of a cash retainer, aligning director pay with shareholder value. Vesting occurs on the earlier of May 13, 2027 or the next annual meeting, with settlement deferred to as late as May 13, 2032.
Such deferred RSU programs are common for boards, smoothing compensation and encouraging longer-term alignment. The filing shows his direct holdings rising to 35,106 shares after the grant, but does not indicate any discretionary buying or selling activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,623 | $38.70 | $295K |
Footnotes (1)
- [object Object]